Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis

S.L. Hauser, A. Bar-Or, G. Comi, G. Giovannoni, H.-P. Hartung, B. Hemmer, F. Lublin, X. Montalban, K.W. Rammohan, K. Selmaj, A. Traboulsee, J.S. Wolinsky, D.L. Arnold, G. Klingelschmitt, D. Masterman, P. Fontoura, S. Belachew, P. Chin, N. Mairon, H. GarrenL. Kappos, Paola Crociani

Research output: Contribution to journalArticle

361 Citations (Scopus)
Original languageEnglish
Pages (from-to)221-234
Number of pages14
JournalNew England Journal of Medicine
Volume376
Issue number3
DOIs
Publication statusPublished - 2017

Cite this

Hauser, S. L., Bar-Or, A., Comi, G., Giovannoni, G., Hartung, H-P., Hemmer, B., ... Crociani, P. (2017). Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis. New England Journal of Medicine, 376(3), 221-234. https://doi.org/10.1056/NEJMoa1601277

Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis. / Hauser, S.L.; Bar-Or, A.; Comi, G.; Giovannoni, G.; Hartung, H.-P.; Hemmer, B.; Lublin, F.; Montalban, X.; Rammohan, K.W.; Selmaj, K.; Traboulsee, A.; Wolinsky, J.S.; Arnold, D.L.; Klingelschmitt, G.; Masterman, D.; Fontoura, P.; Belachew, S.; Chin, P.; Mairon, N.; Garren, H.; Kappos, L.; Crociani, Paola.

In: New England Journal of Medicine, Vol. 376, No. 3, 2017, p. 221-234.

Research output: Contribution to journalArticle

Hauser, SL, Bar-Or, A, Comi, G, Giovannoni, G, Hartung, H-P, Hemmer, B, Lublin, F, Montalban, X, Rammohan, KW, Selmaj, K, Traboulsee, A, Wolinsky, JS, Arnold, DL, Klingelschmitt, G, Masterman, D, Fontoura, P, Belachew, S, Chin, P, Mairon, N, Garren, H, Kappos, L & Crociani, P 2017, 'Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis', New England Journal of Medicine, vol. 376, no. 3, pp. 221-234. https://doi.org/10.1056/NEJMoa1601277
Hauser, S.L. ; Bar-Or, A. ; Comi, G. ; Giovannoni, G. ; Hartung, H.-P. ; Hemmer, B. ; Lublin, F. ; Montalban, X. ; Rammohan, K.W. ; Selmaj, K. ; Traboulsee, A. ; Wolinsky, J.S. ; Arnold, D.L. ; Klingelschmitt, G. ; Masterman, D. ; Fontoura, P. ; Belachew, S. ; Chin, P. ; Mairon, N. ; Garren, H. ; Kappos, L. ; Crociani, Paola. / Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis. In: New England Journal of Medicine. 2017 ; Vol. 376, No. 3. pp. 221-234.
@article{57f6bc469a6247349f3d1026b6e0dafa,
title = "Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis",
author = "S.L. Hauser and A. Bar-Or and G. Comi and G. Giovannoni and H.-P. Hartung and B. Hemmer and F. Lublin and X. Montalban and K.W. Rammohan and K. Selmaj and A. Traboulsee and J.S. Wolinsky and D.L. Arnold and G. Klingelschmitt and D. Masterman and P. Fontoura and S. Belachew and P. Chin and N. Mairon and H. Garren and L. Kappos and Paola Crociani",
note = "Cited By :80 Export Date: 8 March 2018",
year = "2017",
doi = "10.1056/NEJMoa1601277",
language = "English",
volume = "376",
pages = "221--234",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "3",

}

TY - JOUR

T1 - Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis

AU - Hauser, S.L.

AU - Bar-Or, A.

AU - Comi, G.

AU - Giovannoni, G.

AU - Hartung, H.-P.

AU - Hemmer, B.

AU - Lublin, F.

AU - Montalban, X.

AU - Rammohan, K.W.

AU - Selmaj, K.

AU - Traboulsee, A.

AU - Wolinsky, J.S.

AU - Arnold, D.L.

AU - Klingelschmitt, G.

AU - Masterman, D.

AU - Fontoura, P.

AU - Belachew, S.

AU - Chin, P.

AU - Mairon, N.

AU - Garren, H.

AU - Kappos, L.

AU - Crociani, Paola

N1 - Cited By :80 Export Date: 8 March 2018

PY - 2017

Y1 - 2017

U2 - 10.1056/NEJMoa1601277

DO - 10.1056/NEJMoa1601277

M3 - Article

VL - 376

SP - 221

EP - 234

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 3

ER -